Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

Share Price is delayed by 15 minutes
Get Live Data
187.10    0.30 (0.16%)
Bid:
185.70
Ask:
186.20
Spread: 0.50 (0.269%)
Market Cap: £1.88b
BME Live PriceLast checked at - London Stock Exchange

Intraday B&M Share Chart

TR1 Notification

3 Aug 2022 12:12

RNS Number : 8009U
B&M European Value Retail S.A.
03 August 2022
 

TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

B&M European Value Retail SA

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

X

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Details of person subject to the notification obligation

Name

The Capital Group Companies, Inc.

City and country of registered office (if applicable)

Los Angeles, USA

4. Full name of shareholder(s)  (if different from 3.)

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reached:

01/08/2022

6. Date on which issuer notified (DD/MM/YYYY):

03/08/2022

7. Total positions of person(s) subject to the notification obligation:

% of voting rights attached to shares

(total of 8.A)

% of voting rights through financial instruments

(total of 8.B.1 + 8.B.2)

Total of both in %

(8.A + 8.B)

Total number of voting rights of issuer

Resulting situation on the date on which threshold was crossed or reached

9.97%

0.00%

9.97%

1,001,226,836

Position of previous notification (if applicable)

10.08%

0.00%

10.08%

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached:

A: Voting rights attached to shares

Class/type of shares ISIN code (if possible)

Number of voting rights

% of voting rights

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

LU1072616219 Common Stock

90,974,003

9.09%

US05590Y1001 Depository Receipt

8,832,776

0.88%

SUBTOTAL 8.A

99,806,779

9.97%

B 1: Financial Instruments DTR5.3.1R (1) (a)

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

N/A

SUBTOTAL 8.B.1

B 2: Financial Instruments with similar economic effect DTR5.3.1R (1) (b)

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Physical or cash settlement

Number of voting rights

% of voting rights

N/A

SUBTOTAL 8.B.2

9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer

Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary)

X

Name

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Capital Research and Management Company

8.48%

8.48%

Capital International, Inc.

Capital Group Private Client Services, Inc.

Total

9.97%

9.97%

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional information:

 

The Capital Group Companies, Inc. ("CGC") is the parent company of Capital Research and Management Company ("CRMC") and Capital Bank & Trust Company ("CB&T"). CRMC is a U.S.-based investment management company that serves as investment manager to the American Funds family of mutual funds, other pooled investment vehicles, as well as individual and institutional clients. CRMC and its investment manager affiliates manage equity assets for various investment companies through three divisions, Capital Research Global Investors, Capital International Investors and Capital World Investors. CRMC is the parent company of Capital Group International, Inc. ("CGII"), which in turn is the parent company of six investment management companies ("CGII management companies"): Capital International, Inc., Capital International Limited, Capital International Sàrl, Capital International K.K., Capital Group Private Client Services Inc, and Capital Group Investment Management Private Limited. CGII management companies and CB&T primarily serve as investment managers to institutional and high net worth clients. CB&T is a U.S.-based investment management company that is a registered investment adviser and an affiliated federally chartered bank.

Neither CGC nor any of its affiliates own shares of the Issuer for its own account. Rather, the shares reported on this Notification are owned by accounts under the discretionary investment management of one or more of the investment management companies described above.

 

Place of completion

Los Angeles

Date of completion

03/08/2022

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLEAEPDESEAEFA
Date   Source Headline
19th Nov 20244:52 pmRNSPricing of £250 Million Senior Secured Notes
18th Nov 20248:00 amRNSLaunch of £250 million Senior Secured Notes Offer
14th Nov 20247:00 amRNSFY25 Interim Results
31st Oct 20241:00 pmRNSTiming of Announcement of Interim Results
17th Oct 20243:00 pmRNSTR1: Notification of Major Holding in Company
4th Oct 20245:30 pmRNSDirector Declaration
30th Sep 20242:15 pmRNSTotal Voting Rights
13th Sep 20242:51 pmRNSGrant of Share Options to French Senior Management
12th Sep 20244:31 pmRNSPDMR Exercise of Share Options
3rd Sep 20242:15 pmRNSAppointment To Remuneration Committee
2nd Sep 20245:00 pmRNSTotal Voting Rights
29th Aug 20242:45 pmRNSPDMR Shareholding notification
12th Aug 20245:30 pmRNSGrant of Share Options
31st Jul 20245:29 pmRNSTotal Voting Rights
25th Jul 20245:45 pmRNSGrant of Options to Directors
23rd Jul 20242:57 pmRNSEGM Voting results announcement
23rd Jul 20242:15 pmRNSAGM 2024 Voting results announcement
16th Jul 20244:56 pmRNSBlock listing six monthly return
16th Jul 20247:00 amRNSQ1 FY25 Trading Update
19th Jun 20247:00 amRNSNotice of AGM and EGM
17th Jun 202410:00 amRNSGrant of Share Options
13th Jun 20244:50 pmRNSNotice of FY25 Q1 Trading Statement
7th Jun 20243:25 pmRNSPDMR Purchase of Shares
5th Jun 20247:05 amRNSAppointment of new Chair
5th Jun 20247:00 amRNSFY24 Preliminary Results
29th May 20242:30 pmRNSDirector Appointment & Results of OGM
24th Apr 20249:00 amRNSNotice of Ordinary General Meeting
16th Apr 20247:00 amRNSFY24 Post Close Trading Statement
4th Apr 202410:00 amRNSNotice of FY24 Post Close Trading Statement
22nd Mar 20249:00 amRNSBoard Appointment
8th Feb 20249:00 amRNSConfirmation of timing of FY24 Preliminary Results
1st Feb 20241:00 pmRNSMajor Shareholding in Company TR-1
30th Jan 20246:23 pmRNSHolding(s) in Company
24th Jan 202410:00 amRNSPDMR Purchase of Shares
23rd Jan 202412:00 pmRNSB&M Plans Chairman Succession
18th Jan 20242:46 pmRNSNotification of Major Shareholding
15th Jan 20242:20 pmRNSBlock listing Interim Review
9th Jan 20247:00 amRNSGolden Quarter - strong profitable growth
22nd Dec 202312:00 pmRNSCorrection: PDMR announcement
22nd Dec 20238:30 amRNSPost Stabilisation Notice
19th Dec 20239:04 amRNSPCA Notification
15th Dec 20239:00 amRNSNotification of major holdings
13th Dec 202312:10 pmRNSAnnouncement further to recent placing by SSA
30th Nov 20235:41 pmRNSChange of Registered Office
30th Nov 20234:01 pmRNSTotal Voting Rights
28th Nov 20239:22 amRNSDirector/PDMR Shareholding
27th Nov 20235:13 pmRNSNotice of FY24 Third Quarter Trading Statement
24th Nov 202310:35 amRNSPDMR Notification
21st Nov 202311:32 amRNSFinal Results of Tender Offer 3.625% Senior Notes
15th Nov 202310:11 amRNSTender Offer Indicative Maximum Acceptance Amount

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.